The global vaginal slings market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.86% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 1.4 Billion |
Market Forecast in 2033
|
USD 2.4 Billion |
Market Growth Rate (2025-2033) | 5.86% |
Vaginal slings are surgeries treating stress urinary incontinence among women, which includes urine leakage caused by increased pressure in the abdomen. They help close the urethra and bladder neck with a piece of tissue or artificial mesh underneath the urethra. They offer several advantages to patients, such as a small vaginal incision, faster post-operative recovery time, and no requirement for abdominal incision and hospital stay. As a result, they are carried out in hospitals, clinics, and ambulatory surgical centers across the globe.
Due to pregnancy, childbirth, and menopause, which may affect the urinary tract and surrounding muscles, there is a rise in the prevalence of stress urinary incontinence in women. This, along with the growing female geriatric population around the world, represents one of the key factors driving the market. Moreover, the rising awareness among the masses about the benefits of vaginal slings compared to conventional surgeries is contributing to the growth of the market. In addition, there is an increase in the number of hysterectomy cases due to uterine fibroids, which cause pain, bleeding, or other problems. This, coupled with the burgeoning healthcare industry, is strengthening the growth of the market. Besides this, governments of several countries are undertaking initiatives to improve healthcare infrastructure across the globe. Furthermore, the increasing number of gynecological and urological centers to cater to the demand for vaginal sling procedures is positively influencing the market. Apart from this, key market players are extensively investing in research and development (R&D) activities to introduce technologically advanced vaginal sling products, which is expected to propel the growth of the market in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global vaginal slings market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on type, product type, type of urinary incontinence, and end user.
Breakup by Type:
Breakup by Product Type:
Breakup by Type of Urinary Incontinence:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being A.M.I. GmbH, B. Braun Melsungen AG, Betatech Medical, Boston Scientific Corporation, Caldera Medical, Coloplast A/S, Cousin Biotech, Medtronic plc, Neomedic International and Promedon GmbH.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Type, Product Type, Type of Urinary Incontinence, End User, Region |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | A.M.I. GmbH, B. Braun Melsungen AG, Betatech Medical, Boston Scientific Corporation, Caldera Medical, Coloplast A/S, Cousin Biotech, Medtronic plc, Neomedic International and Promedon GmbH |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global vaginal slings market was valued at USD 1.4 Billion in 2024.
We expect the global vaginal slings market to exhibit a CAGR of 5.86% during 2025-2033.
The rising consumer inclination towards vaginal slings over conventional surgeries, as they offer several advantages to patients, such as a small vaginal incision, faster post-operative recovery time, no requirement for abdominal incision and hospital stay, etc., is primarily driving the global vaginal slings market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of numerous elective urinary incontinence surgeries for reducing the risk of the coronavirus infection upon hospital visits and interaction with healthcare professionals, thereby negatively impacting the global market for vaginal slings.
Based on the type, the global vaginal slings market has been divided into conventional vaginal slings and advanced vaginal slings. Currently, conventional vaginal slings exhibit a clear dominance in the market.
Based on the product type, the global vaginal slings market can be categorized into transobturator slings, tension-free vaginal tape sling, and others. Among these, transobturator slings currently hold the majority of the total market share.
Based on the type of urinary incontinence, the global vaginal slings market has been segregated into stress urinary incontinence, urge urinary incontinence, and mixed urinary incontinence. Currently, stress urinary incontinence exhibits a clear dominance in the market.
Based on the end user, the global vaginal slings market can be bifurcated into hospitals, ambulatory surgery centers, and others. Among these, hospitals account for the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global vaginal slings market include A.M.I. GmbH, B. Braun Melsungen AG, Betatech Medical, Boston Scientific Corporation, Caldera Medical, Coloplast A/S, Cousin Biotech, Medtronic plc, Neomedic International, and Promedon GmbH.